In breast cancer, elevated ALDH1 expressions, particularly ALDH1A1 and ALDH1A3, are associated with chemoresistance, particularly cyclophosphamide-based regimens [56,73]. The gene discussed is ALDH1A3; the disease is breast carcinoma.